| 25.88 Data as of May 17 |  +0.26 / +1.01%Today’s Change | 19.02 Today|||52-Week Range 31.36 | +13.71% Year-to-Date |
| ViroPharma (VPHM) Shares Cross Above 200 DMA May 13 / TheStreet.com |
| Previous close | 25.62 |
| Today’s open | 25.71 |
| Day’s range | 25.42 - 25.88 |
| Volume | 326,222 |
| Average volume (3 months) | 537,131 |
| Market cap | $1.7B |
| Dividend yield | -- |
| Earnings growth (last year) | -95.24% |
| Earnings growth (this year) | -1,057.46% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | -21.39% |
| P/E ratio | NM |
| Price/Sales | 3.63 |
| Price/Book | 2.23 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARNAArena Pharmaceutical... | -0.02 | -0.25% |
| IRWDIronwood Pharmaceuti... | -0.21 | -1.44% |
| MNKDMannkind Corp | +0.03 | +0.58% |
| WXWuXi Pharmatech (Cay... | +0.11 | +0.54% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $427.9M |
| Annual profit (last year) | $5.6M |
| Net profit margin | 1.31% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Vincent J. Milano, CPA |
Chief Operating Officer & Vice President Daniel B. Soland |
Corporate headquarters Exton, Pennsylvania |
.
